15 Pharmaceutical Stocks to Buy According to Peter Kolchinsky’s RA Capital
In this piece, we will take a look at the top 15 pharmaceutical stocks to buy according to Peter Kolchinsky's RA Capital.
Nkarta Inc. (NKTX)
Get Email AlertsHedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 5,605,129 | $155,879 | 2.15% | |
| 2. | Samsara BioCapital Srini Akkaraju And Michael Dybbs | 2,034,703 | $56,585 | 8.87% | |
| 3. | Logos Capital Arsani William | 1,275,777 | $35,479 | +28% | 2.55% |
| 4. | Vivo Capital Albert Cha And Frank Kung | 512,225 | $14,245 | 0.63% | |
| 5. | Rock Springs Capital Management Kris Jenner, Gordon Bussard, Graham Mcphail | 503,148 | $13,993 | +2% | 0.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $18.00 | 833,333 | Large Shareholder, Director | 3,150,732 | 2020-07-14 | Filing | |
| $18.00 | 666,666 | Large Shareholder | 2,902,115 | 2020-07-14 | Filing | |
| $18.00 | 666,666 | Large Shareholder | 2,902,115 | 2020-07-14 | Filing | |
| $18.00 | 666,666 | Large Shareholder | 2,902,115 | 2020-07-14 | Filing | |
| $18.00 | 666,666 | Large Shareholder | 2,902,115 | 2020-07-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $15.64 | 4,140 | Officer | 0 | 2021-12-01 | Filing | |
| $26.53 | 223 | Officer, Director | 219,061 | 2021-09-29 | Filing | |
| $27.20 | 8,277 | Officer, Director | 219,284 | 2021-09-29 | Filing | |
| $32.08 | 4,140 | Officer | 0 | 2021-09-01 | Filing | |
| $37.28 | 10,000 | Officer | 0 | 2021-08-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 195 | $3 | 0% | |
| 2. | 0 | $0 | 0% |
News See All
5 Biotech Stocks to Buy Now According to Srini Akkaraju and Michael Dybbs’ Samsara BioCapital
In this article, we will discuss 5 biotech stocks to buy now according to Srini Akkaraju and Michael Dybbs' Samsara BioCapital.
Is NKTX A Good Stock To Buy Now?
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (Recession is Imminent: We Need A Travel Ban NOW).
Billionaire Hedge Funds
